Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up

Motif Bio progresses reverse takeover talks with healthcare company

Wed, 27th Jan 2021

Cash shell Motif Bio said it was continuing to progress a potential reverse takeover deal involving a company in the healthcare sector. Motif Bio said its shares would remain suspended from trading while the proposed deal was negotiated. It said the target was UK-based antibody-drug conjugate discovery and development company, which used clinical experience to develop next-generation therapeutics for the treatment of various cancers. 'The Motif directors are encouraged by the way the proposed transaction is progressing and I look forward to providing our shareholders with further updates and additional information regarding the target in due course,' president and chief business officer Jonathan Gold said. Story provided by

FTSE 100 Latest